Sharemaestro company-news research for Lee's Pharmaceutical Holdings Limited (0950), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
HKG
Hong Kong
Provisional evidence
Company news sentiment
Latest 0950 news and sentiment
Lee's Pharmaceutical Holdings Limited
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score55Neutral is 50
Early balanced news score
36/100 evidence confidence
100% direct company focus
6 current stories across 1 publishers
Current company news
Early balanced news score
6 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone65/100
→
Published 30-day score55/100
Latest source headline
Lee’s Pharmaceutical Declares Interim Cash Dividend for First Half of 2026
TipRanks · 31 Aug 2026 10:36
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
6 current stories are mapped specifically to 0950.
What limits the score
Only 1 publisher currently contribute to the measured read.
The stories agree, but freshness-weighted evidence is only 0.402.
55/100
News scoreEarly balanced news score
36/100
Confidencethin evidence
100%/100
Company news6 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
05 Aug20 Aug03 Sep
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence8
0.402 after freshness weightingSource breadth20
1 independent publishersCompany relevance100
share tied directly to this companyFreshness57
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix0
less reliance on one publisherPrice and news history
Weekly price and news-score history
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
26 completed price weeks10 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
06 Mar02 Jun28 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
28 Aug 202650HKD 1.34+17.5%
21 Aug 202650HKD 1.14-3.8%
14 Aug 202650HKD 1.185+11.8%
07 Aug 202650HKD 1.06-0.9%
31 Jul 202650HKD 1.07-7.8%
24 Jul 202650HKD 1.16+9.4%
17 Jul 202650HKD 1.06-0.9%
10 Jul 202651HKD 1.07+0.9%
Provisional evidence
News subjects
What is shaping the score
Earnings594 stories · 67%
Capital return651 stories · 17%
Market update501 stories · 17%
Source mix
Where the evidence comes from
TipRanks644 stories · 67%
TradingView501 stories · 17%
Moomoo501 stories · 17%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
24 Jun50 neutral01 Sep 03:46
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 01 Sep 03:46 | 54 | +0 | 33/100 (-1) | 6 (0) | Provisional |
| 31 Aug 23:59 | 54 | +4 | 34/100 (+34) | 6 (+2) | Provisional |
| 26 Aug 23:59 | 50 | +0 | 0/100 (0) | 4 (+1) | Insufficient |
| 18 Aug 23:59 | 50 | +0 | 0/100 (0) | 3 (+1) | Insufficient |
| 07 Aug 23:59 | 50 | +0 | 0/100 (-15) | 2 (-1) | Insufficient |
| 01 Aug 23:59 | 50 | -2 | 15/100 (-16) | 3 (0) | Provisional |
| 05 Jul 23:59 | 52 | +2 | 31/100 (+31) | 3 (+1) | Provisional |
| 03 Jul 23:59 | 50 | +0 | 0/100 (0) | 2 (+1) | Insufficient |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#165Tone
TipRanksDirect company coverageScored from headline
Lee’s Pharmaceutical Declares Interim Cash Dividend for First Half of 2026
- Published
- 31 Aug 2026 10:36
- News subject
- Capital return
- Why this score
- Capital returned
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- High · 60/100
- 30-day weight
- 48.4% of the score · 0.7d old
- Duplicates
- 1 consolidated
#266Tone
TipRanksDirect company coverageScored from headline
Lee’s Pharmaceutical Delivers Strong Interim Profit Growth on Higher-Margin Drug Mix
- Published
- 31 Aug 2026 10:36
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- High · 60/100
- 30-day weight
- 51.6% of the score · 0.7d old
- Duplicates
- 1 consolidated
#3—Not directional
TradingViewDirect company coverageScored from headline
Hong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
- Published
- 31 Aug 2026 10:00
- News subject
- Earnings
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 0.7d old
- Duplicates
- 1 consolidated
#4—Not directional
TipRanksDirect company coverageScored from headline
Lee’s Pharmaceutical forecasts higher interim profit on stronger margins and product mix
- Published
- 26 Aug 2026 13:54
- News subject
- Earnings
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 5.6d old
- Duplicates
- 1 consolidated
#5—Not directional
TipRanksDirect company coverageScored from headline
Lee’s Pharmaceutical Sets Board Meeting to Review 2026 Interim Results and Dividend
- Published
- 18 Aug 2026 10:49
- News subject
- Earnings
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 13.7d old
- Duplicates
- 1 consolidated
#6—Not directional
MoomooDirect company coverageScored from headline
Lee's Pharmaceutical Holdings Limited (00950) reported a total transferred position value of HK$46.0725 million, accounting for 7.24%, with 42.4383 million shares transferred out from Bank of China (Hong Kong).
- Published
- 07 Aug 2026 00:27
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 25.1d old
- Duplicates
- 1 consolidated
Earlier company news
0950 news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 7 older 0950 headlines. Open one page at a time when you need them.
Open older archiveHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.